24 Nov

Notification of cessation of securities - KZA

Notification of cessation of +securities Notification of cessation of +securities 1 / 4 Announcement Summary Entity name KAZIA THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday November 24, 2021 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation KZAAA OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 50,000 Expiry of option or other convertible security without exercise or conversion 23/11/2021 Refer to next page for full details of the announcement Notification of cessation of +securities Notification of cessation of +securities 2 / 4 Part 1 - Announcement Details 1.1 Name of +Entity KAZIA THERAPEUTICS LIMITED We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type ACN Registration Number 063259754 1.3 ASX issuer code KZA 1.4 The announcement is 1.5 Date of this announcement 24/11/2021 New announcement Notification of cessation of +securities Notification of cessation of +securities 3 / 4 Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description KZAAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Unquoted +equity securities that have ceased Number of securities that have ceased 50,000 Reason for cessation Expiry of option or other convertible security without exercise or conversion Date of cessation 23/11/2021 Is the entity paying any consideration for the cessation? Any other information the entity wishes to notify to ASX about the cessation? No Notification of cessation of +securities Notification of cessation of +securities 4 / 4 Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue KZA : ORDINARY FULLY PAID 132,552,209 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue KZAAG : OPTION EXPIRING 04-JAN-2025 EX $1.69 200,000 KZAAF : OPTION EXPIRING 09-NOV-2024 EX $1.132 1,200,000 KZAAD : OPTION EXPIRING 13-NOV-2023 EX $0.4925 1,200,000 KZAAB : OPTION EXPIRING 09-NOV-2024 EX $0.8812 800,000 KZAAE : OPTION EXPIRING 13-JAN-2025 EX $0.8812 200,000 KZAAC : CONVERTIBLE NOTES 1,865,000 KZAAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 280,500 KZAAN : OPTION EXPIRING 16-NOV-2025 EX $1.69 1,000,000 KZAAO : OPTION EXPIRING 16-NOV-2025 EX $2.24 1,500,000 KZAAP : OPTION EXPIRING 16-NOV-2026 EX $1.56 800,000 KZAAH : OPTION EXPIRING 21-JUN-2026 EX $1.365 100,000 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

More from Kazia Therapeutics Limited


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Kazia Therapeutics Limited (ASX:KZA) when you join Listcorp.